Sign up for free insights newsletter
EM

EMEIS SA

EMEISEuronext Paris

Need professional-grade analysis? Visit stockanalysis.com

€12.97
-3.43%
End of day
Market Cap

$2.48B

P/E Ratio

N/A

Employees

83,500

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.35-0.54-0.180.62-0.96-0.46
Calmar-4.88-1.21-0.290.88-0.71-0.72
Sharpe-1.67-0.40-0.120.40-0.22-0.22
Omega0.590.961.021.121.091.01
Martin-9.60-3.15-0.562.10-0.82-1.29
Ulcer7.976.2711.1011.7586.9230.13

EMEIS SA (EMEIS) Price Performance

EMEIS SA (EMEIS) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR12.97, down 3.43% from the previous close.

Over the past year, EMEIS has traded between a low of EUR10.00 and a high of EUR15.71. The stock has gained 13.8% over this period. It is currently 17.4% below its 52-week high.

EMEIS SA has a market capitalization of $2.48B.

About EMEIS SA

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its services include concierge, housekeeping, ironing, internet connection, TV, telephone, free shuttles, catering and event organization, access to common areas, logistics support, DIY and gardening assistance, IT support, beauty and relaxation treatments, furniture on rent, fitness and wellness areas, and medical visits. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, schizophrenic disorders, autism spectrum disorders, psychotraumatic disorders, neurodegenerative diseases, Perinatal psychiatry, and burn-out. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the United Kingdom, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.

Company Info

Exchange
Euronext Paris
Currency
EUR
Country
France

Financial Metrics

Revenue (TTM)
$5.77B
EBITDA
$758.19M
Profit Margin
-5.07%
EPS (TTM)
-1.76
Book Value
9.84

Technical Indicators

52 Week High
€16.19
52 Week Low
€8.42
50 Day MA
€14.21
200 Day MA
€13.01
Beta
0.47

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
0.43
Price/Book
1.56
Enterprise Value
$9.78B